<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>5
<FILENAME>a2104660zex-10_13.htm
<DESCRIPTION>EX 10.13
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03CHI1813_4">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="kc1813_exhibit_10.13"> </A>
<A NAME="toc_kc1813_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit 10.13    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portions
of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by
asterisks ("*****"), and the omitted text has been filed separately with the Securities and Exchange Commission. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>NON-TERMINATION AGREEMENT REGARDING THE CLEARING 21 &reg;<BR>
SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT RESTATEMENT<BR>
EFFECTIVE JANUARY 30, 2001  </B></FONT></P>

<P><FONT SIZE=2><B>BETWEEN:  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EURONEXT PARIS, S.A., a corporation organized and existing under the laws of the Republic of France with a stated capital of 130 332 568 Euros and having its
principal office at 39, rue Cambon 75001 Paris, FRANCE, registered with the Trade Registry of PARIS under N<SUP>o</SUP>&nbsp;B 343 406 732 ("EURONEXT") </FONT></P>

<P><FONT SIZE=2><B>AND  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CHICAGO MERCANTILE EXCHANGE&nbsp;INC., a corporation organized under the laws of the State of Delaware and having its principal office at 30 South Wacker Drive,
Chicago, Illinois 60606 ("CME") </FONT></P>

<P><FONT SIZE=2><B>AND  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NEW YORK MERCANTILE EXCHANGE,&nbsp;INC., a New York Corporation having an office at One North End Avenue, World Financial Center, New York, New York
10281-1101, USA ("NYMEX"). </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>RECITALS:  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, EURONEXT, CME, and NYMEX have entered into a Clearing 21 &reg; Software Marketing and
Distribution Agreement (Restatement effective as of January&nbsp;30, 2001) (the "Remarketing Agreement") pursuant to which EURONEXT may, under certain conditions, promote, market and license the
CLEARING 21 Base Product and Derivative Works to Prospective Users. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, pursuant to Section&nbsp;8.2 of the Remarketing Agreement, the initial term of the Remarketing Agreement shall continue *****. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, further pursuant to Section&nbsp;8.2 of the Remarketing Agreement, the Remarketing Agreement was to be renewed automatically
for successive terms of three years unless, not later than twelve (12)&nbsp;months prior to the expiration of the initial term or any successive term, CME and NYMEX jointly notify EURONEXT of their
intentions to terminate the Remarketing Agreement or EURONEXT notifies CME and NYMEX of its intentions to terminate the Remarketing Agreement. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, *****. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, EURONEXT wishes to obtain assurances from CME and NYMEX that they will not terminate the Remarketing Agreement *****. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS</B></FONT><FONT SIZE=2>, EURONEXT, CME and NYMEX wish to amend Section&nbsp;8.2 of the Remarketing Agreement, subject to the specific terms set forth
herein and in accordance with the terms of the Remarketing Agreement that are not significantly amended by this Agreement, to amend the duration and termination timeline for successive terms of the
Remarketing Agreement. </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=840560,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813A.;3',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>NOW THEREFORE,</B></FONT><FONT SIZE=2> in exchange for ten (10)&nbsp;US dollars and in consideration of the premises and the mutual promises and agreements
herein expressed, the parties hereto agree as follows: </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE 1&#151;TERMINATION PROVISIONS  </B></FONT></P>

<P><FONT SIZE=2><B>1.1.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>CME, EURONEXT, and NYMEX agree that the second and third sentences of </FONT> <FONT SIZE=2><B>Section&nbsp;8.2</B></FONT><FONT SIZE=2> (Term; Renewal) of the Remarketing Agreement
are hereby deleted and replaced with the following sentences: </FONT></P>

<UL>

<P><FONT SIZE=2>The
Agreement shall be renewed automatically for successive terms of six (6)&nbsp;months; provided, however, that Licensee may notify Licensors or Licensors, acting jointly, may notify Licensee of
their respective intentions to terminate participation in the Agreement at the end of any successive term not later than one (1)&nbsp;month prior to the expiration of such successive term. </FONT></P>

</UL>

<P><FONT SIZE=2><B>1.2.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>CME and NYMEX shall not, individually or jointly, seek to terminate the Remarketing Agreement at the *****. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>ARTICLE 2&#151;GENERAL  </B></FONT></P>

<P><FONT SIZE=2><B>2.1.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>All the terms and conditions of the Remarketing Agreement not modified by the terms of this Agreement shall remain in effect. </FONT></P>


<P><FONT SIZE=2><B>2.2.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>This Agreement contains the complete and exclusive statement of the Agreement between CME, NYMEX and EURONEXT with respect to the
subject matter hereof and supercedes all prior and contemporaneous agreements, understandings, proposals, negotiations, representations, or warranties of any kind, whether oral or written. </FONT></P>

<P><FONT SIZE=2><B>2.3.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>All actions arising from disputes initiated by CME or NYMEX in connection with this Agreement shall be heard and finally settled under
the Rules of Conciliation and Arbitration of the International Chamber of Commerce by one or more arbitrators appointed in accordance with said Rules. Resolution of all such disputes shall be governed
in all respects by the substantive laws of the Republic of France. The arbitration proceeding related thereto shall be conducted in English. The place of arbitration in such cases shall be Zurich,
Switzerland. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
actions arising from disputes initiated by EURONEXT in connection with this Agreement shall be heard and finally settled in the federal or state courts located in the City of New
York, State of New
York. Resolution of all such disputes shall be governed by the substantive laws of the State of New York without recourse to choice of law principles. </FONT></P>

<P><FONT SIZE=2><B>2.4.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>If any provision of this Agreement is declared by a court of competent jurisdiction to be invalid, illegal, or unenforceable, the
parties agree that such invalidity, illegality, or unenforceability shall not affect the validity of the remaining provisions of this Agreement and further agree to substitute for the invalid
provision a valid provision which approximates the intent and economic effect of the invalid provision as closely as possible. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>IN WITNESS WHEREOF</B></FONT><FONT SIZE=2>, CME, NYMEX and EURONEXT have executed this Agreement effective this 26&nbsp;day of December&nbsp;2002. </FONT></P>

<P><FONT SIZE=2><B>CHICAGO MERCANTILE EXCHANGE&nbsp;INC.</B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
Craig S. Donohue<BR>
By: Mr.&nbsp;Craig S. Donohue </FONT></P>

<P><FONT SIZE=2>Title:
Executive Vice-President and Chief Administrative Officer </FONT></P>

<P><FONT SIZE=2><B>EURONEXT PARIS, S.A.  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2><BR>
&nbsp;&nbsp;&nbsp;&nbsp;/s/ Jean-Fran&ccedil;ois Th&eacute;odore<BR>
By: Mr.&nbsp;Jean-Fran&ccedil;ois Th&eacute;odore<BR>
Title: Chairman and Chief Executive Officer</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2><BR>
For Jean-Fran&ccedil;ois Th&eacute;odore<BR>
Patrick Stephan<BR>
Executive Director, Legal</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=2,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=881841,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813A.;3',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->

<P><FONT SIZE=2><B>NEW YORK MERCANTILE EXCHANGE,&nbsp;INC.  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;/s/
J. Robert Collins, Jr.<BR>
By: Mr.&nbsp;J. Robert Collins, Jr. </FONT></P>

<P><FONT SIZE=2>Title:
President </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=3,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=687527,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813A.;3',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->
<P ALIGN="CENTER"><FONT SIZE=2><B>AMENDMENT NO. 1 TO THE<BR>
CLEARING 21 &reg; SOFTWARE MARKETING AND DISTRIBUTION AGREEMENT<BR>
RESTATEMENT EFFECTIVE JANUARY 30, 2001  </B></FONT></P>

<P><FONT SIZE=2><B>BETWEEN:  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EURONEXT PARIS, S.A., a corporation organized and existing under the laws of the Republic of France with a stated capital of 130 332 568 Euros and having its
principal office 39, rue Cambon 75001 Paris, FRANCE, registered with the Trade Registry of PARIS under N<SUP>o</SUP>&nbsp;B 343 406 732 (the "Licensee") </FONT></P>

<P><FONT SIZE=2><B>AND  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CHICAGO MERCANTILE EXCHANGE&nbsp;INC., a corporation organized under the laws of the State of Delaware and having its principal office situated at 30 South
Wacker Drive, Chicago, Illinois 60606 ("CME") </FONT></P>

<P><FONT SIZE=2><B>AND  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NEW YORK MERCANTILE EXCHANGE,&nbsp;INC., a New York Corporation having an office at One North End Avenue, World Financial Center, New York, New York
10281-1101, USA ("NYMEX") </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CME
and NYMEX are hereinafter referred to together as the "Licensors." </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><B>RECITALS:  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>WHEREAS,</B></FONT><FONT SIZE=2> CME, NYMEX, and Licensee have entered into a Clearing 21&reg; Software Marketing and Distribution
Agreement (Restatement effective as of January&nbsp;30, 2001) (the "Agreement") pursuant to which Licensee may, under certain conditions, promote, market and license the CLEARING 21 Base Product and
Derivative Works to Prospective Users. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS,</B></FONT><FONT SIZE=2> pursuant to Sections 2.4 (Prospective Users Reserved by Licensors) and 3.4 (Excluded Prospective Users) of the Agreement, CME
expressly excluded from the Agreement the right for Licensee to promote, market or sublicense the CLEARING 21 Base Product and Derivative Works to *****. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>WHEREAS,</B></FONT><FONT SIZE=2> Licensors are now willing to authorize Licensee, subject to the specific conditions set forth herein and in accordance with those
terms of the Agreement that are not significantly amended by this Amendment, to promote, market or sublicense the CLEARING 21 Base Product and Derivative Works to *****. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>NOW THEREFORE</B></FONT><FONT SIZE=2>, in consideration of the premises and the mutual promises and undertakings herein expressed, Licensors and Licensee hereby
agree as follows: </FONT></P>

<P><FONT SIZE=2><B>1.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.1.</B></FONT><FONT SIZE=2> (Definitions) of the Agreement is hereby amended to include the following new defined terms: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2><B>(s)</B></FONT></DT><DD><FONT SIZE=2>"Market Segment" means a group of products that are all traded on the same Cleared Market or Additional Cleared Market and that fall
into one of the following categories of products: (a)&nbsp;equity securities, (b)&nbsp;equity options, (c)&nbsp;futures contracts and options on futures contracts, (d)&nbsp;cash transactions
of debt, (e)&nbsp;spot transactions of currencies, physical goods, services, commodities, energy, materials and livestock, and (f)&nbsp;all other instruments including, without limitation, all
other derivative instruments.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2><B>(t)</B></FONT></DT><DD><FONT SIZE=2>"Cleared Market" means each of the following: LIFFE, London Stock Exchange, London Metal Exchange, International Petroleum Exchange,
Intercontinental Exchange, Tradepoint/Virt-x, LCH RepoClear and SwapClear.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2><B>(u)</B></FONT></DT><DD><FONT SIZE=2>"Additional Cleared Markets" means any exchange, trading platform, OTC market or other market other than a Cleared Market for which
***** provides clearing services after the effective date of this Amendment, whether established through a clearing arrangement </FONT></DD></DL>
</UL>
<HR NOSHADE>
<!-- ZEQ.=4,SEQ=4,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=389674,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813B.;14',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->
<UL>
<UL>

<P><FONT SIZE=2>between
***** and a new party or through the merger, acquisition, or consolidation of a Cleared Market with another Cleared Market or party. </FONT></P>

</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2><B>(v)</B></FONT></DT><DD><FONT SIZE=2>"*****" means the *****. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2><B>2.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.4</B></FONT><FONT SIZE=2> of the Agreement is hereby amended to include the following new Section&nbsp;2.4.1: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="78%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="7%"><FONT SIZE=2>2.4.1.</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2>Notwithstanding Section&nbsp;2.4. and Schedule&nbsp;1 hereto, Licensors hereby grant to Licensee and Licensee hereby accepts from Licensors, in accordance with the terms and conditions of this Agreement, an exclusive,
non-transferable, worldwide license, only until December&nbsp;31, 2003, to promote and market the CLEARING 21 Base Product and Derivative Works to ***** and to license and distribute the CLEARING 21 Base Product and Derivative Works to *****, without
the right to further sublicense or distribute the same, solely for use by ***** in connection with the clearing and settling of all Market Segments of Cleared Markets and Additional Cleared Markets. Any license arrangement entered into between
Licensee and ***** must be documented in a signed, written agreement, which complies in all material respects with the requirements set forth in Section&nbsp;3.6 hereof ("***** Sublicense Agreement"). The term of the ***** Sublicense Agreement shall
not exceed ***** from its date of execution.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2><B>3.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.4</B></FONT><FONT SIZE=2> (Excluded Prospective Users) of the Agreement is hereby amended to include the following new Section&nbsp;3.4.1: </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="78%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="6%"><FONT SIZE=2>3.4.1</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="88%"><FONT SIZE=2>Notwithstanding anything to the contrary in this Agreement, Licensee shall not be entitled to any reimbursements from Licensors for promotion and marketing to ***** pursuant to this Agreement.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2><B>4.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.1</B></FONT><FONT SIZE=2> (*****) of the Agreement is hereby amended to include the following new Section&nbsp;5.1(f): </FONT></P>

<UL>

<P><FONT SIZE=2>Notwithstanding
any contrary terms contained in this Agreement relating to *****, the following ***** conditions shall apply to the ***** Sublicense Agreement: </FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD><FONT SIZE=2>*****.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD><FONT SIZE=2>*****.
</FONT></DD></DL>
</UL>

<P><FONT SIZE=2><B>5.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2</B></FONT><FONT SIZE=2> (Standard Revenue Sharing) of the Agreement is hereby renumbered as Section&nbsp;5.2(a). </FONT></P>


<P><FONT SIZE=2><B>6.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2</B></FONT><FONT SIZE=2> (Standard Revenue Sharing) of this Agreement is hereby amended to include the following new Section&nbsp;5.2(b): </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>*****.
</FONT></DD></DL>
</UL>

<P><FONT SIZE=2><B>7.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6</B></FONT><FONT SIZE=2> (Maintenance Services) of the Agreement is hereby renumbered as Article&nbsp;5.6(a) and the first sentence of the
renumbered Section&nbsp;5.6(a) is hereby deleted and replaced with the following sentence: </FONT></P>

<UL>

<P><FONT SIZE=2>Maintenance
services related to any sublicense or sublicense upgrade shall be offered to all Sublicensees by Licensee or its affiliate ATOS-EURONEXT SA, a French limited company
incorporated under the laws of France, with offices at Palais de la Bourse, Place de la Bourse, 75002 Paris, France. </FONT></P>

</UL>
<HR NOSHADE>
<!-- ZEQ.=5,SEQ=5,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=902486,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813B.;14',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->

<P><FONT SIZE=2><B>8.&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6</B></FONT><FONT SIZE=2> (Maintenance Services) of the Agreement is hereby amended to include the following new Section&nbsp;5.6(b): </FONT></P>

<UL>

<P><FONT SIZE=2>Notwithstanding
the provisions of Section&nbsp;5.6(a) of the Agreement, with respect to maintenance services provided to *****, CME shall only be entitled to receive from Licensee the greater of
***** per month or ***** of the monthly maintenance fee charged by Licensee to *****. </FONT></P>

</UL>

<P><FONT SIZE=2><B>9.&nbsp;&nbsp;&nbsp;&nbsp;Schedule&nbsp;1</B></FONT><FONT SIZE=2> (Prospective Users Reserved by CME) of the Agreement is hereby amended to add the following phrase in front of the
reference to *****: "Except as expressly permitted in this Agreement,". </FONT></P>

<P><FONT SIZE=2><B>10.&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT SIZE=2>All the terms and conditions of the Agreement not modified by the terms of this Amendment shall remain in effect. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>IN WITNESS WHEREOF</B></FONT><FONT SIZE=2>, Licensors and Licensee have executed this Amendment on this 26&nbsp;day of December&nbsp;2002. </FONT></P>

<P><FONT SIZE=2><B>EURONEXT PARIS  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="49%"><FONT SIZE=2><BR>
&nbsp;&nbsp;&nbsp;&nbsp;/s/ Jean-Fran&ccedil;ois Th&eacute;odore<BR>
By: Mr.&nbsp;Jean-Fran&ccedil;ois Th&eacute;odore<BR>
Title: Chairman and Chief Executive Officer</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="49%"><FONT SIZE=2><BR>
For Jean-Fran&ccedil;ois Th&eacute;odore<BR>
Patrick Stephan<BR>
Executive Director, Legal</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2><B>CHICAGO MERCANTILE EXCHANGE&nbsp;INC.  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;/s/
Craig S. Donohue </FONT></P>

<P><FONT SIZE=2>By:
Mr.&nbsp;Craig S. Donohue </FONT></P>

<P><FONT SIZE=2>Title:
Executive Vice-President and Chief Administrative Officer </FONT></P>


<P><FONT SIZE=2><B>NEW YORK MERCANTILE EXCHANGE,&nbsp;INC.  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;/s/
J. Robert Collins, Jr. </FONT></P>

<P><FONT SIZE=2>By:
Mr.&nbsp;J. Robert Collins, Jr. </FONT></P>

<P><FONT SIZE=2>Title:
President </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=6,SEQ=6,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4",CHK=676398,FOLIO='blank',FILE='DISK020:[03CHI3.03CHI1813]KC1813B.;14',USER='VSTEFAN',CD='21-MAR-2003;03:56' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03CHI1813_4">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_kc1813_1">Exhibit 10.13</A></FONT><BR>
</UL>
<!-- SEQ=,FILE='QUICKLINK',USER=JKANTOR,SEQ=,EFW="2104660",CP="CHICAGO MERC EXCHANGE HOLDINGS",DN="4" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
